Latest news
BioMarin Buy Rating Reaffirmed as Strong Voxzogo Performance and Pipeline Progress Support Durable Growth; $94 Price Target Maintained - TipRanksTipRanks · Fri, 07 Aug 2026 15:52:41 GMTBioMarin Lifts 2026 Outlook on Strong Voxzogo Sales, Wedbush Says - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 15:44:27 GMTBMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook Raised - Zacks Investment ResearchZacks Investment Research · Fri, 07 Aug 2026 15:04:26 GMTBioMarin Pharmaceutical Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 23:03:49 GMTBioMarin Reports Second Quarter 2026 Financial and Operating Results - TradingViewTradingView · Thu, 06 Aug 2026 20:03:00 GMT